Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Dec 17, 2019
Open Peer Review Period: Dec 17, 2019 - Jan 31, 2020
Date Accepted: Mar 22, 2020
Date Submitted to PubMed: Apr 29, 2020
(closed for review but you can still tweet)
Towards earlier diagnosis in rheumatology using combined eHealth tools: The JPAST Project
Outcomes of patients with inflammatory rheumatic diseases have significantly improved over the last three decades, mainly due to therapeutic innovations, more timely treatment and a recognition of the need to monitor response to treatment and to titrate treatments accordingly. A major challenge for all stakeholders remains diagnostic delay. The combination of eHealth, serologic and genetic markers holds greats promise to improve the current management of patients with inflammatory rheumatic diseases by speeding up access to appropriate care. The Joint Pain Assessment Scoring Tool (JPAST) project, funded by the European Union (EU) European Institute of Innovation and Technology (EIT) Health program is a unique European project aiming to enable and accelerate personalized precision medicine for early treatment in rheumatology, ultimately also enabling prevention. The aim of the project is to facilitate this while at the same time reducing cost for society and patients.
Request queued. Please wait while the file is being generated. It may take some time.
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.